+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neurostimulation Devices Market Size, Share & Trends Analysis Report by Application (Pain Management, Parkinson's Disease), by Product (Spinal Cord Stimulator, Gastric Electric Stimulator), and Segment Forecasts, 2022-2030

  • ID: 3934190
  • Report
  • April 2022
  • Region: Global
  • 102 Pages
  • Grand View Research

FEATURED COMPANIES

  • Codman & Shurtleff’S
  • Cyberonics
  • Intrapace
  • Medtronic
  • Neuronetics, Inc.
  • Nevro Corporation
The global neurostimulation devices market size is expected to reach USD 14.8 billion by 2030, registering a CAGR of 12.8% over the forecast period. Increasing prevalence of chronic diseases, such as migraine and epilepsy, due to unhealthy diets & lifestyle, and rising geriatric population across the globe are expected to be the major growth-driving factors for the market. On the other hand, adverse effects and risks associated with neurostimulation devices and stringent regulations regarding product approval are expected to hamper the market growth to some extent. The increasing incidence of Road Traffic Accidents (RTAs) is another key factor supporting the market development.



In addition, manufacturers are investing in R&D activities to develop new products with advanced technology, such as MRI safety-incorporated devices by Medtronic Inc. and minimally invasive transdermal neuromodulation technology by Neurowave Medical Technologies. Asia Pacific is projected to be the fastest-growing regional market from 2022 to 2030 on account of the rising healthcare expenditures and rapid economic growth in emerging countries, such as India and China. The presence of unmet medical needs and untapped markets are also boosting the market growth in the region. Moreover, changing lifestyles and eating habits resulting in various lifestyle-related diseases will contribute to the regional market growth. The growing cases of RTAs and resultant nerve injuries, which require neurostimulation postoperatively, are also likely to boost the product demand.

Neurostimulation Devices Market Report Highlights

  • North America is estimated to dominate the global market over the forecast period due to the rising product demand as an add-on therapy and high disposable income & patient awareness levels.
  • The presence of sophisticated healthcare infrastructure and the growing prevalence of target diseases, such as epilepsy, Parkinson’s disease, and incontinence, are expected to drive the market growth further.
  • The spinal cord stimulation product segment led the market in 2021 as these devices were the prime neurostimulation products to be commercialized.
  • Pain management was the dominant application segment in 2021, in terms of revenue share, due to the high prevalence of chronic pain disorders and extensive product usage for pain management.
  • New product and technological developments are the key business strategies followed by most of the market players.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Neurostimulation Devices Market

What is the estimated value of the Global Neurostimulation Devices Market?

The Global Neurostimulation Devices Market was estimated to be valued at $5.6 Billion in 2022.

What is the growth rate of the Global Neurostimulation Devices Market?

The growth rate of the Global Neurostimulation Devices Market is 12.8%, with an estimated value of $14.8 Billion by 2030.

What is the forecasted size of the Global Neurostimulation Devices Market?

The Global Neurostimulation Devices Market is estimated to be worth $14.8 Billion by 2030.

Who are the key companies in the Global Neurostimulation Devices Market?

Key companies in the Global Neurostimulation Devices Market include Medtronic, St. Jude Medical, Boston Scientific Corporation, Cyberonics, Nevro Corporation, Neuronetics, Inc., Uroplasty and Intrapace.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Codman & Shurtleff’S
  • Cyberonics
  • Intrapace
  • Medtronic
  • Neuronetics, Inc.
  • Nevro Corporation

Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.4 Purchased database
1.5 internal database
1.6 Secondary sources & third party perspectives
1.7 Primary research
1.8 Information analysis
1.9 Data analysis models
1.10 Market formulation & data visualization
1.11 Data validation & publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Neurostimulation Devices Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Product Pipeline Analysis, by Stage
3.4 Industry Value Chain Analysis
3.4.1 Cost Structure Analysis
3.4.2 User Perspective Analysis
3.4.2.1 Consumer behavior analysis
3.4.2.2 Market influencer analysis
3.4.3 Cost Analysis Breakdown
3.4.4 List Of Key End Users, by Region
3.5 Technology Overview
3.5.1 TECHNOLOGY TIMELINE
3.6 Regulatory Framework
3.6.1 Reimbursement Framework
3.6.2 Standards and Compliances
3.7 Market Dynamics
3.7.1 Market Driver Analysis
3.7.1.1 Growing geriatric population base
3.7.1.2 Introduction of technological advancements
3.7.1.3 Growing demand for neurostimulation devices as an add on therapy
3.7.1.4 Increasing global prevalence of chronic diseases
3.7.1.5 Growing prevalence of lifestyle-induced disorders
3.7.1.6 External funding for executing research and development exercises
3.7.1.7 Growing demand for minimally invasive surgeries
3.7.2 Market Restraint Analysis
3.7.2.1 Adverse effects and risks associated with neurostimulation devices
3.7.2.2 Presence of stringent device approval regulations
3.7.2.3 Availability of external substitutes or alternative therapeutic procedures
3.7.3 Industry Challenges
3.7.3.1 Presence of ambiguous regulatory framework
3.8 Neurostimulation Devices Market Analysis Tools
3.8.1 Industry Analysis-Porter's Five Forces
3.8.1.1 Supplier Power
3.8.1.2 Buyer Power
3.8.1.3 Substitution Threat
3.8.1.4 Threat from new entrants
3.8.1.5 Competitive Rivalry
3.8.2 PESTEL Analysis
3.8.2.1 Political Landscape
3.8.2.2 Environmental Landscape
3.8.2.3 Social landscape
3.8.2.4 Technology landscape
3.8.2.5 Legal Landscape
3.8.3 Major Deals and Strategic Alliances Analysis
3.8.3.1 Joint ventures
3.8.3.2 Mergers and acquisitions
3.8.3.3 Licensing and partnership
3.8.3.4 Technology collaborations
3.8.3.5 Strategic Divestments
3.8.4 Market Entry Strategies
3.8.5 Case Studies
Chapter 4 Neurostimulation Devices Market-Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Categorization
4.3 Vendor Landscape
4.3.1 List Of Key Distributors and Channel Partners
4.3.2 Key Customers
4.3.3 Key Company Market Share Analysis, 2021
4.4 Public Companies
4.4.1 Company Market Position Analysis
4.4.2 Company Market Share, by Region
4.4.3 Competitive Dashboard Analysis
4.4.3.1 Market Differentiators
4.4.3.2 Synergy Analysis: Major Deals and Strategic Alliances
4.5 Private Companies
4.5.1 List Of Key Emerging Companies
4.5.2 Regional Network Map
4.5.3 Company Market Position Analysis
4.5.4 Supplier Ranking
Chapter 5 Neurostimulation Devices Market: Product Estimates and Trend Analysis
5.1 Definition & Scope
5.2 Product Market Share Analysis, 2021
5.3 Segment Dashboard
5.4 Global Neurostimulation Devices Market, by Product, 2018-2030
5.5 Market Size & Forecasts and Trend Analyses, 2018-2030
5.5.1 Spinal Cord Stimulator
5.5.1.1 Spinal Cord Stimulators Market, 2018-2030 (USD Million)
5.5.1.2 Spinal Cord Stimulators Market, 2018-2030 (‘000 Units)
5.5.1.3 Spinal Cord Stimulator Market, by Application, 2018-2030 (USD Million)
5.5.2 Deep Brain Stimulator
5.5.2.1 Deep Brain Stimulators Market, 2018-2030 (USD Million)
5.5.2.2 Deep Brain Stimulators Market, 2018-2030 (‘000 Units)
5.5.2.3 Deep Brain Stimulators Market, by Application, 2018-2030 (USD Million)
5.5.3 Sacral Nerve Stimulators Market
5.5.3.1 Sacral Nerve Stimulators Market, 2018-2030 (USD Million)
5.5.3.2 Sacral Nerve Stimulators Market, 2018-2030 (‘000 Units)
5.5.3.3 Sacral Nerve Stimulators Market, by Application, 2018-2030 (USD Million)
5.5.4 Vagus Nerve Stimulators Market
5.5.4.1 Vagus Nerve Stimulators Market, 2018-2030 (USD Million)
5.5.4.2 Vagus Nerve Stimulators Market, 2018-2030 (‘000 Units)
5.5.4.3 Vagus Nerve Stimulators, by Application, 2018-2030 (USD Million)
5.5.5 Gastric Electric Stimulators Market
5.5.5.1 Gastric Electric Stimulators Market, 2018-2030 (USD Million)
5.5.5.2 Gastric Electric Stimulators Market, 2018-2030 (‘000 Units)
5.5.5.3 Gastric Electric Stimulators, by Application, 2018-2030 (USD Million)
Chapter 6 Neurostimulation Devices Market: Application Estimates and Trend Analysis
6.1 Definition & Scope
6.2 Application Market Share Analysis, 2021
6.3 Segment Dashboard
6.4 Global Neurostimulation Devices Market, by Application, 2018-2030
6.5 Market Size & Forecasts and Trend Analyses, 2018-2030
6.5.1 Neurostimulation Devices For Pain Management Market
6.5.1.1 Neurostimulation Devices For Pain Management Market, 2018-2030 (USD Million)
6.5.2 Neurostimulation Devices For Epilepsy Market
6.5.2.1 Neurostimulation Devices For Epilepsy Market, 2018-2030 (USD Million)
6.5.3 Neurostimulation Devices For Essential Tremor Market
6.5.3.1 Neurostimulation Devices For Essential Tremor Market, 2018-2030 (USD Million)
6.5.4 Neurostimulation Devices For Urinary and Fecal Incontinence Market
6.5.4.1 Neurostimulation Devices For Urinary and Fecal Incontinence Market, 2018-2030 (USD Million)
6.5.5 Neurostimulation Devices For Depression Market
6.5.5.1 Neurostimulation Devices For Depression Market, 2018-2030 (USD Million)
6.5.6 Neurostimulation Devices For Dystonia Market
6.5.6.1 Neurostimulation Devices For Dystonia Market, 2018-2030 (USD Million)
6.5.7 Neurostimulation Devices For Gastroparesis Market
6.5.7.1 Neurostimulation Devices For Gastroparesis Market, 2018-2030 (USD Million)
6.5.8 Neurostimulation Devices For Parkinson's Disease Market
6.5.8.1 Neurostimulation Devices For Parkinson's Disease Market, 2018-2030 (USD Million)
6.5.9 Neurostimulation Devices For Other Diseases Market
6.5.9.1 Neurostimulation Devices For Other Diseases Market, 2018-2030 (USD Million)
Chapter 7 Neurostimulation Devices Market: Regional Estimates & Trend Analysis
7.1 Regional Market Snapshot
7.2 Regional Market Share and Leading Players, 2021
7.2.1 North America
7.2.2 Europe
7.2.3 Latin America
7.2.4 Asia Pacific
7.2.5 Middle East & Africa
7.3 Market Share Analysis by Country, 2021
7.3.1 North America
7.3.1.1 U.S.
7.3.1.2 Canada
7.3.2 Europe.
7.3.2.1 U.K.
7.3.2.2 Germany
7.3.2.3 Spain
7.3.2.4 France
7.3.2.5 Italy
7.3.2.6 Russia
7.3.3 Latin America
7.3.3.1 Brazil
7.3.3.2 Mexico
7.3.3.3 Argentina
7.3.4 Asia Pacific
7.3.4.1 Japan
7.3.4.2 China
7.3.4.3 India
7.3.4.4 South Korea
7.3.4.5 Singapore
7.3.4.6 Australia
7.3.5 Middle East & Africa
7.3.5.1 South Africa
7.3.5.2 Saudi Arabia
7.3.5.3 UAE
7.4 Swot Analysis, by Factor (Political & Legal, Economic and Technological)
7.4.1 North America
7.4.2 Europe
7.4.3 Latin America
7.4.4 Asia Pacific
7.4.5 Middle East & Africa
7.5 Market Size & Forecasts, and Trend Analysis, 2021
7.5.1 North America
7.5.1.1 North America Market Size, & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.1.2 U.S.
7.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.1.3 Canada
7.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.2 Europe
7.5.2.1 Europe Market Size, & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.2.2 U.K.
7.5.2.2.1 U.K. Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.2.3 Germany
7.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.2.4 Spain
7.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.2.5 France
7.5.2.5.1 France Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.2.6 Italy
7.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.2.7 Russia
7.5.2.7.1 Russia Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.3 Latin America
7.5.3.1 Latin America Market Size, & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.3.2 Brazil
7.5.3.2.1 Brazil Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.3.3 Mexico
7.5.3.3.1 Mexico Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.3.4 Argentina
7.5.3.4.1 Argentina Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.4 Asia Pacific
7.5.4.1 Asia Pacific Market Size, & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.4.2 Japan
7.5.4.2.1 Japan Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.4.3 China
7.5.4.3.1 China Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.4.4 India
7.5.4.4.1 India Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.4.5 South Korea
7.5.4.5.1 South Korea Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.4.6 Singapore
7.5.4.6.1 Singapore Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.4.7 Australia
7.5.4.7.1 Australia Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.5 Middle East & Africa
7.5.5.1 the Middle East & Africa Market Size, & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.5.2 South Africa
7.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.5.3 Saudi Arabia
7.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
7.5.5.4 UAE
7.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, 2018-2030 (USD Million)
Chapter 8 Company Profiles
8.1 Company Profiles
8.1.1 MEDTRONIC
8.1.1.1 Company overview
8.1.1.2 Financial Performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 ST. JUDE MEDICAL
8.1.2.1 Company overview
8.1.2.2 Financial Performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 BOSTON SCIENTIFIC CORPORATION
8.1.3.1 Company overview
8.1.3.2 Financial Performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 CYBERONICS
8.1.4.1 Company overview
8.1.4.2 Financial Performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 NEVRO CORPORATION
8.1.5.1 Company overview
8.1.5.2 Financial Performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6 NEURONETICS, INC.
8.1.6.1 Company overview
8.1.6.2 Financial Performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 UROPLASTY
8.1.7.1 Company overview
8.1.7.2 Financial Performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 CODMAN & SHURTLEFF’S
8.1.8.1 Company overview
8.1.8.2 Financial Performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 INTRAPACE
8.1.9.1 Company overview
8.1.9.2 Financial Performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
Note: Product cover images may vary from those shown
  • MEDTRONIC
  • ST. JUDE MEDICAL
  • BOSTON SCIENTIFIC CORPORATION
  • CYBERONICS
  • NEVRO CORPORATION
  • NEURONETICS, INC.
  • UROPLASTY
  • CODMAN & SHURTLEFF’S
  • INTRAPACE
Note: Product cover images may vary from those shown

Loading
LOADING...